Bionomics Limited (BNOX)
USD 0.25
(4.59%)
USD 0.25
(4.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -15.49 Billion USD | -48541.02% |
| 2023 | -31.85 Million USD | -46.37% |
| 2022 | -21.76 Million USD | -150.11% |
| 2021 | -8.7 Million USD | -22.19% |
| 2020 | -7.12 Million USD | 26.37% |
| 2019 | -9.67 Million USD | 47.92% |
| 2018 | -18.56 Million USD | -257.91% |
| 2017 | -5.18 Million USD | 58.03% |
| 2016 | -12.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4.93 Million USD | 68.42% |
| 2024 Q4 | -81.41 Thousand USD | 0.0% |
| 2024 Q2 | -15.37 Million USD | -211.15% |
| 2023 Q3 | -5.22 Million USD | 67.75% |
| 2023 Q1 | -5.18 Million USD | 13.77% |
| 2023 Q2 | -16.21 Million USD | -212.74% |
| 2023 FY | -21.21 Million USD | -41.19% |
| 2023 Q4 | -15.64 Million USD | -199.18% |
| 2022 Q4 | -6.01 Million USD | 0.0% |
| 2022 FY | -15.02 Million USD | -130.36% |
| 2022 Q2 | -9.48 Million USD | 0.0% |
| 2021 Q2 | -9818.81 USD | 0.0% |
| 2021 Q4 | -8.68 Million USD | 0.0% |
| 2021 FY | -6.52 Million USD | -62.39% |
| 2020 FY | -4.01 Million USD | 45.01% |
| 2020 Q2 | -4.56 Million USD | 0.0% |
| 2020 Q4 | -464.96 Thousand USD | 0.0% |
| 2019 Q4 | 1.07 Million USD | 0.0% |
| 2019 FY | -7.3 Million USD | 60.66% |
| 2018 FY | -18.56 Million USD | -257.91% |
| 2017 FY | -5.18 Million USD | 58.03% |
| 2016 FY | -12.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -10482.225% |
| Alkermes plc | 355.75 Million USD | 4454.704% |
| Agenus Inc. | -245.76 Million USD | -6203.753% |
| Aptorum Group Limited | -2.82 Million USD | -548363.79% |
| Ardelyx, Inc. | -66.06 Million USD | -23349.174% |
| Dyadic International, Inc. | -6.79 Million USD | -227878.146% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -1655045.94% |
| Lantern Pharma Inc. | -15.96 Million USD | -96959.38% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -81313.954% |
| Novavax, Inc. | -545.06 Million USD | -2742.276% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -26476.375% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -20894.94% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -83433.304% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -155038.854% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -26165.624% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -4046.392% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -63550.849% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -41389.464% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -9313.495% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -21021.745% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -76249.938% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -24785.015% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -47590.214% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -11592.818% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -3419.011% |
| AlloVir, Inc. | -190.41 Million USD | -8035.873% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -7447.03% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -54350.183% |
| Bicycle Therapeutics plc | -180.66 Million USD | -8475.126% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -8552.279% |
| ChromaDex Corporation | -4.93 Million USD | -313633.617% |
| Chimerix, Inc. | -82.09 Million USD | -18771.023% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -34633.216% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -15077.982% |
| CRISPR Therapeutics AG | -153.61 Million USD | -9985.389% |
| Precision BioSciences, Inc. | -61.31 Million USD | -25164.871% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -9526.768% |
| Fortress Biotech, Inc. | -60.63 Million USD | -25449.031% |
| Fortress Biotech, Inc. | -60.63 Million USD | -25449.031% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -18890.152% |
| ImmuCell Corporation | -5.77 Million USD | -268181.29% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -13614.615% |
| Immix Biopharma, Inc. | -15.42 Million USD | -100328.613% |
| Incyte Corporation | 597.59 Million USD | 2692.402% |
| Innoviva, Inc. | 179.72 Million USD | 8720.072% |
| IO Biotech, Inc. | -86.08 Million USD | -17896.778% |
| Jaguar Health, Inc. | -41.3 Million USD | -37411.298% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -10026.128% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 29804.655% |
| ContextLogic Inc. | -317 Million USD | -4787.119% |
| MiMedx Group, Inc. | 67.43 Million USD | 23072.117% |
| MEI Pharma, Inc. | 17.77 Million USD | 87242.344% |
| NextCure, Inc. | -62.72 Million USD | -24599.338% |
| Onconetix, Inc. | -37.4 Million USD | -41312.17% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -39141.536% |
| Opthea Limited | -220.24 Million USD | -6934.153% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -30182.358% |
| Vaxcyte, Inc. | -402.26 Million USD | -3751.224% |
| PDS Biotechnology Corporation | -42.94 Million USD | -35976.789% |
| Precigen, Inc. | -95.9 Million USD | -16053.827% |
| Pharming Group N.V. | -10.54 Million USD | -146773.019% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -7584.911% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -63022.544% |
| PureTech Health plc | -65.69 Million USD | -23481.238% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -61643.916% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -7200.05% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -63550.849% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -5908.651% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -56777.032% |
| Acelyrin, Inc. | -381.64 Million USD | -3959.356% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -123515397.872% |
| Summit Therapeutics Inc. | -614.92 Million USD | -2419.346% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -45330.24% |
| Senti Biosciences, Inc. | -92.91 Million USD | -16572.764% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -14696.861% |
| Elevation Oncology, Inc. | -45.7 Million USD | -33796.74% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -43986.983% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -118415.355% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -231645.191% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -52662.639% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -182139.337% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -26836.807% |
| Seer, Inc. | -86.27 Million USD | -17856.31% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -23024.362% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -23456.855% |
| ESSA Pharma Inc. | -26.58 Million USD | -58179.912% |
| GlycoMimetics, Inc. | -36.89 Million USD | -41884.85% |
| GT Biopharma, Inc. | -7.59 Million USD | -203824.786% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -6318.67% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -29735.659% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 21794.673% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -28366.734% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -31439.426% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -155635.44% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -2604.435% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -431677.202% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -30242.289% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -6208.014% |
| Aptose Biosciences Inc. | -51.2 Million USD | -30154.0% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -15660.417% |
| Soligenix, Inc. | -6.14 Million USD | -252185.412% |
| Century Therapeutics, Inc. | -136.67 Million USD | -11235.206% |
| Kura Oncology, Inc. | -152.63 Million USD | -10050.078% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -17264.395% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -146912.393% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 2739797.243% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -2722600.527% |
| Autolus Therapeutics plc | -208.38 Million USD | -7334.467% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -21447.423% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -21783.136% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -71397.905% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -6777.765% |
| GRI Bio, Inc. | -13.03 Million USD | -118732.293% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -374597.635% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -12385.225% |
| IGM Biosciences, Inc. | -246.41 Million USD | -6186.997% |
| INmune Bio, Inc. | -30 Million USD | -51526.786% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -13912.578% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -36616.7% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -96958.626% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -97982.828% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -25856.549% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -15213.458% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -5510.542% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -6412.269% |
| Verastem, Inc. | -87.36 Million USD | -17632.286% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -28489.662% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -9502.424% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -13179.986% |
| Histogen Inc. | -10.62 Million USD | -145763.535% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -108337.255% |
| Surrozen, Inc. | -43.04 Million USD | -35893.137% |
| Organovo Holdings, Inc. | -14.67 Million USD | -105497.205% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -304442.514% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -29499.683% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -61223.54% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -57410.454% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -185277.607% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -10153.94% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -31564.458% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -52018.304% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -148609.984% |
| Apollomics, Inc. | -172.6 Million USD | -8875.71% |
| Amarin Corporation plc | -59.11 Million USD | -26108.157% |
| Mesoblast Limited | -87.95 Million USD | -17513.541% |
| Turnstone Biologics Corp. | -55.2 Million USD | -27965.518% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -10441.613% |
| Synaptogenix, Inc. | -6.03 Million USD | -256456.359% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -95483.453% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -19756.66% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -323228.309% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -184282.345% |
| Exelixis, Inc. | 207.76 Million USD | 7556.581% |
| Better Therapeutics, Inc. | -39.76 Million USD | -38864.2% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -10662.335% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -2830.637% |
| NLS Pharmaceutics AG | -12.17 Million USD | -127176.775% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -198652.818% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -50282.666% |
| Gritstone bio, Inc. | -138.49 Million USD | -11086.487% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -23931.903% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -387208.991% |
| Avid Bioservices, Inc. | -140.75 Million USD | -10906.633% |
| Insmed Incorporated | -749.56 Million USD | -1966.815% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -101892.546% |
| MediWound Ltd. | -6.71 Million USD | -230575.491% |
| OmniAb, Inc. | -50.61 Million USD | -30505.437% |
| Alector, Inc. | -130.39 Million USD | -11781.315% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -13522.6% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -29780.545% |
| Zai Lab Limited | -334.62 Million USD | -4529.779% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -4681.739% |
| Aura Biosciences, Inc. | -76.4 Million USD | -20175.581% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -6502.751% |
| Immunic, Inc. | -93.61 Million USD | -16449.338% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -11300.268% |
| Veracyte, Inc. | -74.4 Million USD | -20721.684% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -201737.862% |
| FibroGen, Inc. | -284.23 Million USD | -5350.535% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -58958.272% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -221156.918% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -82162.081% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 3834.564% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -68586.172% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 31542.768% |
| TG Therapeutics, Inc. | 12.67 Million USD | 122355.098% |
| Galecto, Inc. | -38.34 Million USD | -40297.836% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -82016.856% |
| Fortrea Holdings Inc. | -3.4 Million USD | -455551.941% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -12132.846% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -88879.186% |
| XBiotech Inc. | -24.55 Million USD | -62986.558% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -23931.903% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -24616.283% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -15639.912% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -72202.077% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -27969.078% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -2453.77% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -22597.482% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -27210645.776% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -6738.631% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -69472.93% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -6951.188% |
| NexImmune, Inc. | -32.34 Million USD | -47797.534% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -292947.369% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -110196.752% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 491.85% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -63861.711% |
| Scopus BioPharma Inc. | -11.6 Million USD | -133340.111% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -13164.068% |
| Ainos, Inc. | -13.77 Million USD | -112402.167% |
| Pluri Inc. | -20.88 Million USD | -74067.781% |
| Prothena Corporation plc | -147.02 Million USD | -10436.881% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -13505.014% |
| Celularity Inc. | -196.29 Million USD | -7792.288% |
| Rallybio Corporation | -74.56 Million USD | -20677.005% |
| Cue Biopharma, Inc. | -50.73 Million USD | -30436.664% |
| MeiraGTx Holdings plc | -84.02 Million USD | -18337.129% |
| Omeros Corporation | -117.81 Million USD | -13049.793% |
| Humacyte, Inc. | -110.77 Million USD | -13885.129% |
| Immunocore Holdings plc | -55.28 Million USD | -27921.354% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -86044.161% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -67459.923% |
| Blueprint Medicines Corporation | -506.98 Million USD | -2955.75% |
| CalciMedica, Inc. | -34.35 Million USD | -44991.731% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -22792.007% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -10855.883% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -9244.508% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -5369.335% |
| Pulmatrix, Inc. | -14.12 Million USD | -109610.12% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -43918.088% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -18647.024% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -3119.539% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -14672.593% |
| Cytokinetics, Incorporated | -526.24 Million USD | -2843.913% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -42856.235% |
| Nutriband Inc. | -5.48 Million USD | -282329.885% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -38227.971% |
| Vor Biopharma Inc. | -117.86 Million USD | -13044.215% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 456.23% |
| Evogene Ltd. | -23.87 Million USD | -64777.784% |
| ProKidney Corp. | -35.46 Million USD | -43579.277% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -12835.686% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -197368.399% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | -2308.6% |
| CorMedix Inc. | -46.33 Million USD | -33332.077% |
| BioLineRx Ltd. | -60.61 Million USD | -25458.726% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -15126.614% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -37625.043% |
| Atai Life Sciences N.V. | -40.22 Million USD | -38414.732% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -19109.093% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -20413.719% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -5202.068% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -55475.283% |
| MediciNova, Inc. | -8.57 Million USD | -180640.093% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -12466.956% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -184840.587% |
| GeoVax Labs, Inc. | -25.96 Million USD | -59561.524% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -6375.629% |
| Biomea Fusion, Inc. | -117.25 Million USD | -13112.371% |
| PTC Therapeutics, Inc. | -626.6 Million USD | -2372.401% |
| Mereo BioPharma Group plc | -29.46 Million USD | -52476.413% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -10014.889% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -7299.774% |
| Absci Corporation | -110.56 Million USD | -13911.691% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -51283.635% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -15263.573% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -6466.23% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 110098.339% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -7928.61% |
| Allakos Inc. | -185.7 Million USD | -8242.532% |
| Imunon, Inc. | -19.51 Million USD | -79286.033% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -15816.336% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 14695.973% |
| BioAtla, Inc. | -123.46 Million USD | -12448.125% |
| NLS Pharmaceutics AG | -12.17 Million USD | -127176.775% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -96256.301% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -4633.829% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -41828.512% |
| XOMA Corporation | -40.83 Million USD | -37842.166% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -15107.781% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -12972.124% |
| aTyr Pharma, Inc. | -50.38 Million USD | -30645.135% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -17569.186% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -10108.4% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -6416.597% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -44013.346% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -191351.815% |
| Akari Therapeutics, Plc | -10 Million USD | -154697.822% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -23010915.225% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 5601.597% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -232344.123% |
| UroGen Pharma Ltd. | -102.24 Million USD | -15052.152% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -14406.724% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -199100.199% |
| Orgenesis Inc. | -55.36 Million USD | -27883.898% |
| Entera Bio Ltd. | -8.88 Million USD | -174184.689% |
| GH Research PLC | -35.58 Million USD | -43433.217% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -74238.608% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -19918.822% |
| Xencor, Inc. | -126.08 Million USD | -12186.886% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -411301.805% |
| Replimune Group, Inc. | -215.79 Million USD | -7079.146% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -72747.62% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 617563.77% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -232344.123% |
| Portage Biotech Inc. | -75.33 Million USD | -20463.275% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -184840.587% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -15928.313% |
| OncoCyte Corporation | -27.78 Million USD | -55665.329% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -115364.867% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -139198.999% |
| Purple Biotech Ltd. | -19.88 Million USD | -77828.4% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -220617.567% |
| scPharmaceuticals Inc. | -54.81 Million USD | -28165.218% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -88395.603% |
| HilleVax, Inc. | -123.56 Million USD | -12437.564% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -153181.547% |
| Tharimmune, Inc. | -9.31 Million USD | -166141.117% |
| Genprex, Inc. | -30.86 Million USD | -50100.695% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -6466.564% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -51379.252% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -869269.585% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -292424.965% |
| OKYO Pharma Limited | -16.82 Thousand USD | -92075635.225% |
| Savara Inc. | -54.69 Million USD | -28223.094% |
| Curis, Inc. | -47.41 Million USD | -32574.933% |
| Daré Bioscience, Inc. | -30.16 Million USD | -51264.229% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -100204.815% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -278085.778% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -51860.979% |
| BeiGene, Ltd. | -881.7 Million USD | -1657.063% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -72653.668% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -3450.261% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -19521.514% |
| Erasca, Inc. | -125.04 Million USD | -12289.57% |
| bluebird bio, Inc. | -211.91 Million USD | -7210.626% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -309712.525% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 9341.055% |
| DBV Technologies S.A. | -72.72 Million USD | -21202.101% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -309712.525% |
| Moderna, Inc. | -4.71 Billion USD | -228.642% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -38478.992% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -271978.785% |
| Molecular Templates, Inc. | -8.12 Million USD | -190596.283% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -25554.378% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -13806.917% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -11345.835% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -32229.903% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -10854.024% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -7951.643% |
| MacroGenics, Inc. | -9.05 Million USD | -170932.965% |
| RenovoRx, Inc. | -10.23 Million USD | -151308.972% |
| Adicet Bio, Inc. | -142.65 Million USD | -10759.655% |
| Prime Medicine, Inc. | -198.13 Million USD | -7719.074% |
| Aditxt, Inc. | -32.38 Million USD | -47743.621% |
| Adagene Inc. | -18.94 Million USD | -81668.518% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -211781.194% |
| Quantum-Si incorporated | -95.96 Million USD | -16044.4% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -12915.455% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -106172.551% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 11807.221% |
| SciSparc Ltd. | -5.12 Million USD | -302363.217% |
| Vericel Corporation | -3.18 Million USD | -486768.825% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -12882769.593% |
| Minerva Neurosciences, Inc. | -30 Million USD | -51531.341% |
| Generation Bio Co. | -126.61 Million USD | -12135.938% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -21153.88% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -18691.594% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -5809.883% |
| Invivyd, Inc. | -198.64 Million USD | -7698.999% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -4430.231% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -178246.121% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 68030.22% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -156798.582% |
| 2seventy bio, Inc. | -217.57 Million USD | -7020.543% |
| ADMA Biologics, Inc. | -28.23 Million USD | -54760.887% |
| Clene Inc. | -49.5 Million USD | -31194.776% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -69410.429% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -31239.091% |
| GeoVax Labs, Inc. | -25.96 Million USD | -59561.524% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -4622.271% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -47505.346% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 68287.35% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -15581.64% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -20624.197% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -9534.132% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -2418.802% |
| Evaxion Biotech A/S | -22.12 Million USD | -69921.089% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -19088.672% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -7643.45% |
| Trevena, Inc. | -40.28 Million USD | -38352.595% |
| Surrozen, Inc. | -43.04 Million USD | -35893.137% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -22308.896% |
| Cingulate Inc. | -23.53 Million USD | -65726.22% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -224034.346% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -38766.448% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -200818.467% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -17073.446% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -25178.475% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -25935.941% |
| Clearmind Medicine Inc. | -11.95 Million USD | -129487.0% |
| Kronos Bio, Inc. | -112.67 Million USD | -13649.67% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -22288.494% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -610834327.477% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -17936.167% |
| Statera Biopharma, Inc. | -174.4 Million USD | -8782.707% |
| ImmunityBio, Inc. | -583.19 Million USD | -2556.425% |
| Korro Bio, Inc. | -81.17 Million USD | -18985.603% |
| Kineta, Inc. | -14.09 Million USD | -109781.311% |
| BioVie Inc. | -32.12 Million USD | -48131.348% |
| Codexis, Inc. | -76.24 Million USD | -20220.26% |
| Celularity Inc. | -196.29 Million USD | -7792.288% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -7121.479% |
| Celcuity Inc. | -63.77 Million USD | -24190.343% |
| Virax Biolabs Group Limited | -6.73 Million USD | -229974.714% |
| Cibus, Inc. | -267.62 Million USD | -5688.716% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -38317.314% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -43160.914% |
| IN8bio, Inc. | -30 Million USD | -51528.507% |
| Kodiak Sciences Inc. | -260.49 Million USD | -5847.294% |
| Annexon, Inc. | -134.23 Million USD | -11440.906% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -13122.52% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -25202.42% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -49012.877% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -4129.527% |
| Eyenovia, Inc. | -27.26 Million USD | -56728.845% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 71852.888% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -2895631.963% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -20176.643% |
| Arcellx, Inc. | -70.69 Million USD | -21815.64% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -37283.668% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -11477.215% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -51476.942% |
| Moolec Science SA | -51.78 Million USD | -29814.078% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -29481.574% |
| Geron Corporation | -184.12 Million USD | -8313.848% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -36808.958% |
| Royalty Pharma plc | 1.13 Billion USD | 1465.148% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -11294.985% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -174129.748% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -72827.541% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -8924.387% |
| Humacyte, Inc. | -110.77 Million USD | -13885.129% |
| Structure Therapeutics Inc. | -89.62 Million USD | -17186.505% |
| 89bio, Inc. | -142.18 Million USD | -10795.474% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -22365.438% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -149193.302% |
| Genelux Corporation | -28.29 Million USD | -54648.44% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -53201.793% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -8646.756% |
| Notable Labs, Ltd. | -11.26 Million USD | -137436.985% |
| Liquidia Corporation | -78.5 Million USD | -19634.741% |
| Mustang Bio, Inc. | -51.6 Million USD | -29922.414% |
| Immunovant, Inc. | -259.33 Million USD | -5873.782% |
| Quantum-Si incorporated | -95.96 Million USD | -16044.4% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -21166.134% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -79834.812% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -16039.354% |
| Acasti Pharma Inc. | -12.85 Million USD | -120433.463% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -68883.272% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -96958.626% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -8393.838% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -360055.871% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -124135.493% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -52431.844% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -39635.729% |
| PepGen Inc. | -78.62 Million USD | -19603.617% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -51941.271% |
| United Therapeutics Corporation | 984.8 Million USD | 1673.128% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -69496.433% |
| Solid Biosciences Inc. | -96.01 Million USD | -16035.152% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -323228.309% |
| Immuneering Corporation | -53.47 Million USD | -28872.688% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -304442.514% |
| Silo Pharma, Inc. | -3.7 Million USD | -418529.912% |
| Belite Bio, Inc | -31.63 Million USD | -48876.246% |
| XOMA Corporation | -40.83 Million USD | -37842.166% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -28396.581% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -18346.349% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -53033.608% |
| uniQure N.V. | -308.47 Million USD | -4922.13% |
| Cassava Sciences, Inc. | -97.21 Million USD | -15835.655% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -211781.194% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -12451.378% |
| Forte Biosciences, Inc. | -31.47 Million USD | -49118.98% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -188789.625% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -53196.291% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -2895631.963% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -58958.272% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -93877.349% |
| Altimmune, Inc. | -88.44 Million USD | -17415.762% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -10120.186% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -53033.608% |
| Compugen Ltd. | -18.75 Million USD | -82507.262% |
| Peak Bio, Inc. | -1259.26 USD | -1230259417.494% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -33542.785% |
| Benitec Biopharma Inc. | -21.75 Million USD | -71125.075% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -4472.793% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -18575.611% |
| Zura Bio Limited | -60.36 Million USD | -25566.279% |
| PolyPid Ltd. | -23.86 Million USD | -64815.843% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -98375.502% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -18575.611% |
| Instil Bio, Inc. | -156.08 Million USD | -9825.34% |
| argenx SE | -295.05 Million USD | -5150.638% |
| Immunome, Inc. | -106.8 Million USD | -14404.959% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -36357.302% |
| Verona Pharma plc | -54.36 Million USD | -28394.484% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -15405.035% |
| Shattuck Labs, Inc. | -87.29 Million USD | -17646.301% |
| CervoMed Inc. | -2.17 Million USD | -713209.019% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -12328.433% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -116242.49% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -35469.202% |
| Moolec Science SA | -51.78 Million USD | -29814.078% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -89592821.009% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -11365.712% |
| AnaptysBio, Inc. | -163.61 Million USD | -9368.439% |
| Design Therapeutics, Inc. | -66.86 Million USD | -23070.36% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -18928.872% |
| NeurAxis, Inc. | -14.62 Million USD | -105817.152% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -40795.85% |
| Lumos Pharma, Inc. | -34.03 Million USD | -45419.674% |
| Achilles Therapeutics plc | -69.66 Million USD | -22138.091% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -15405.035% |
| 180 Life Sciences Corp. | -19.93 Million USD | -77612.962% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 514996.885% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -610834327.477% |
| Nutriband Inc. | -5.48 Million USD | -282329.885% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -15284.933% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -31772.294% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -19995.946% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -45505.434% |
| MoonLake Immunotherapeutics | -36 Million USD | -42925.118% |
| Palisade Bio, Inc. | -12.3 Million USD | -125852.569% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -36677.528% |
| Beam Therapeutics Inc. | -132.52 Million USD | -11589.819% |
| Neurogene Inc. | -36.31 Million USD | -42558.166% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -9380.259% |
| AEON Biopharma, Inc. | -52.55 Million USD | -29377.445% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -15684.656% |
| Sesen Bio, Inc. | -19.88 Million USD | -77812.724% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -21541.94% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -123699.702% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -3388.936% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -13786.1% |
| Athira Pharma, Inc. | -117.67 Million USD | -13065.55% |
| Vaccinex, Inc. | -20.25 Million USD | -76400.746% |
| HCW Biologics Inc. | -24.99 Million USD | -61882.853% |
| XOMA Corporation | -40.83 Million USD | -37842.166% |
| Nektar Therapeutics | -276.05 Million USD | -5511.965% |
| Arvinas, Inc. | -367.3 Million USD | -4117.851% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -23010915.225% |
| Merus N.V. | -154.93 Million USD | -9898.881% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -15801.143% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -49261.689% |
| Rezolute, Inc. | -68.45 Million USD | -22529.846% |
| Clene Inc. | -49.5 Million USD | -31194.776% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -100345.393% |
| BeyondSpring Inc. | -21.02 Million USD | -73580.995% |
| Synlogic, Inc. | -57.28 Million USD | -26945.435% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -130075.33% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -143001.478% |
| Peak Bio, Inc. | -1259.26 USD | -1230259417.494% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -41358.376% |
| Krystal Biotech, Inc. | 10.93 Million USD | 141813.922% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -10726.187% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -4665.295% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -335303.407% |
| MannKind Corporation | -11.93 Million USD | -129671.871% |
| Ikena Oncology, Inc. | -68.16 Million USD | -22627.116% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -73619.562% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -16570.253% |
| Gossamer Bio, Inc. | -179.81 Million USD | -8515.518% |
| CohBar, Inc. | -11.96 Million USD | -129410.215% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -59975.097% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -51283.635% |
| Legend Biotech Corporation | -518.25 Million USD | -2889.3% |
| Mural Oncology plc | -207.44 Million USD | -7368.012% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -12382.106% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -84604.204% |
| Disc Medicine, Inc. | -76.42 Million USD | -20170.01% |
| Champions Oncology, Inc. | -7.27 Million USD | -212821.468% |
| REGENXBIO Inc. | -263.49 Million USD | -5779.514% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -145872.468% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -32511.654% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -40686.572% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -15366.955% |
| Vaxart, Inc. | -82.46 Million USD | -18686.353% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 4641766.692% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -41165.664% |
| Cellectis S.A. | -101.05 Million USD | -15229.823% |
| Longeveron Inc. | -21.41 Million USD | -72249.349% |
| Repare Therapeutics Inc. | -93.79 Million USD | -16416.873% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -2790.454% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -21668.138% |
| Revolution Medicines, Inc. | -436.36 Million USD | -3450.261% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -235665.728% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -50160.077% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -22244.578% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -23832.778% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -157806.085% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 528.008% |
| Denali Therapeutics Inc. | -145.22 Million USD | -10567.773% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -12882769.593% |
| Veru Inc. | -93.15 Million USD | -16530.938% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -57216.83% |
| Cingulate Inc. | -23.53 Million USD | -65726.22% |
| Passage Bio, Inc. | -102.06 Million USD | -15079.171% |
| Context Therapeutics Inc. | -23.96 Million USD | -64547.094% |
| Exicure, Inc. | -16.91 Million USD | -91493.745% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -8100.515% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -40923.636% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -237972.746% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -8288.745% |
| Nuvalent, Inc. | -126.21 Million USD | -12174.036% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -147224.77% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -17731.888% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -50620.816% |
| OmniAb, Inc. | -50.61 Million USD | -30505.437% |
| Anew Medical, Inc. | 1.34 Million USD | 1150971.279% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -96454.478% |
| Lipocine Inc. | -16.35 Million USD | -94641.245% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -23233.684% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -24230.06% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -36616.7% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -32197.55% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -78020.952% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -2761.031% |
| Ocugen, Inc. | -63.07 Million USD | -24460.332% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -16082.85% |
| Q32 Bio Inc. | -112.96 Million USD | -13614.615% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -90012.645% |
| Alumis Inc. Common Stock | -154.99 Million USD | -9895.397% |
| Equillium, Inc. | -13.33 Million USD | -116076.723% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -25563.728% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -193846.971% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -82081.212% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -26121.465% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -13427.086% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -84197.556% |
| Dominari Holdings Inc. | -22.88 Million USD | -67604.598% |
| Edesa Biotech, Inc. | -8.37 Million USD | -184894.009% |
| vTv Therapeutics Inc. | -20.25 Million USD | -76404.523% |
| Bio-Techne Corporation | 168.1 Million USD | 9315.768% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -4300.084% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 12123.132% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -12616.007% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -40734.408% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -13653.454% |
| Nkarta, Inc. | -117.5 Million USD | -13084.71% |
| BioCardia, Inc. | -11.57 Million USD | -133787.875% |
| Iterum Therapeutics plc | -38.37 Million USD | -40274.674% |